FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kaspar Berneis

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Procedures

Electrophoresis, Polyacrylamide Gel

Co-author Network

Publications

TOP 3
Isabelle Aeberli; Kaspar Berneis; Annina Erb; Graham S Finlayson; Mark Fox; Heiko Frühauf; Max Gassmann; Oliver Götze; Wolfgang Langhans; Marco Maggiorini; Daniela Meier; Kerstin Spliethoff; Thomas A Lutz
Disturbed eating at high altitude: influence of food preferences, acute mountain sickness and satiation hormones.
Heiner K. Berthold; Wilhelm Krone; Christos S Mantzoros; Kaspar Berneis; Ioanna Gouni-Berthold
Effects of simvastatin and ezetimibe on interleukin-6 and high-sensitivity C-reactive protein.
Philipp A Gerber; Ioanna Gouni-Berthold; Kaspar Berneis
Omega-3 Fatty acids: role in metabolism and cardiovascular disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kaspar Berneis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Isabelle Aeberli; Kaspar Berneis; Annina Erb; Graham S Finlayson; Mark Fox; Heiko Frühauf; Max Gassmann; Oliver Götze; Wolfgang Langhans; Marco Maggiorini; Daniela Meier; Kerstin Spliethoff; Thomas A Lutz
Disturbed eating at high altitude: influence of food preferences, acute mountain sickness and satiation hormones.
European journal of nutrition 2013;52(2):625-35.
2013: Heiner K. Berthold; Wilhelm Krone; Christos S Mantzoros; Kaspar Berneis; Ioanna Gouni-Berthold
Effects of simvastatin and ezetimibe on interleukin-6 and high-sensitivity C-reactive protein.
Scandinavian cardiovascular journal : SCJ 2013;47(1):20-7.
2013: Philipp A Gerber; Ioanna Gouni-Berthold; Kaspar Berneis
Omega-3 Fatty acids: role in metabolism and cardiovascular disease.
Current pharmaceutical design 2013;19(17):3074-93.
2013: Isabelle Aeberli; Philip A Gerber; Michel Hochuli; Stefanie B Murer; Giatgen A Spinas; Lisa Sze; Luc Tappy; Kaspar Berneis
Moderate amounts of fructose consumption impair insulin sensitivity in healthy young men: a randomized controlled trial.
Diabetes care 2013;36(1):150-6.
2012: Zuzana Sopkova; Giatgen A Spinas; Radovan Tisko; Kaspar Berneis; Zuzana Dorkova; Manfredi Rizzo; Ruzena Tkacova
Size and subclasses of low-density lipoproteins in patients with obstructive sleep apnea.
Angiology 2012;63(8):617-21.
2012: Philipp A Gerber; Kaspar Berneis
Regulation of low-density lipoprotein subfractions by carbohydrates.
Current opinion in clinical nutrition and metabolic care 2012;15(4):381-5.
2011: Dimitri P Mikhailidis; Klaus G Parhofer; Giovam Battista Rini; Manfredi Rizzo; Giatgen A Spinas; Gerald H Tomkin; Alexandros D Tselepis; Anthony S Wierzbicki; Karl Winkler; Alberto Zambon; Vasilios Athyros; Kaspar Berneis; Jacqueline de Graaf; Moses Elisaf; Matilda Florentin; Bruce Griffin; Winfried März; Evangelos Liberopoulos
"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses: executive summary.
Current vascular pharmacology 2011;9(5):531-2.
2011: Dimitri P Mikhailidis; Klaus G Parhofer; Giovam Battista Rini; Manfredi Rizzo; Giatgen A Spinas; Gerald H Tomkin; Alexandros D Tselepis; Anthony S Wierzbicki; Karl Winkler; Alberto Zambon; Vasilios Athyros; Kaspar Berneis; Jacqueline de Graaf; Moses Elisaf; Matilda Florentin; Bruce Griffin; Winfried März; Evangelos Liberopoulos
"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses.
Current vascular pharmacology 2011;9(5):533-71.
2011: Isabelle Aeberli; Heiner K Berthold; Philipp A Gerber; Ioanna Gouni-Berthold; Sarah R Haile; Michel Hochuli; Sibylle Kohler; Giatgen A Spinas; Kaspar Berneis
Low to moderate sugar-sweetened beverage consumption impairs glucose and lipid metabolism and promotes inflammation in healthy young men: a randomized controlled trial.
The American journal of clinical nutrition 2011;94(2):479-85.
2010: Manfredi Rizzo; Kaspar Berneis; S Koulouris; Socrates Pastromas; Giovam Battista Rini; D Sakellariou; Antonis S Manolis
Should we measure routinely oxidised and atherogenic dense low-density lipoproteins in subjects with type 2 diabetes?
International journal of clinical practice 2010;64(12):1632-42.
2010: Manfredi Rizzo; Giatgen A Spinas; Giovam Battista Rini; Kaspar Berneis
Is diabetes the cost to pay for a greater cardiovascular prevention?
International journal of cardiology 2010;144(2):309-10.
2010: Zeynep Ozbalkan; cumali efe; Mustafa Cesur; Sibel Ertek; Narin Nasiroglu; Kaspar Berneis; Manfredi Rizzo
An update on the relationships between rheumatoid arthritis and atherosclerosis.
Atherosclerosis 2010;212(2):377-82.
2010: Stephanie Kiencke; Rolf Handschin; Ruth von Dahlen; Jürgen Muser; Hans-Peter Brunner-LaRocca; Jörg Schumann; Barbara Felix; Kaspar Berneis; Peter Rickenbacher
Pre-clinical diabetic cardiomyopathy: prevalence, screening, and outcome.
European journal of heart failure 2010;12(9):951-7.
2010: Julia H Goedecke; Kristina Utzschneider; Mirjam V Faulenbach; Manfredi Rizzo; Kaspar Berneis; Giatgen A Spinas; Joel A Dave; Naomi S Levitt; Estelle V Lambert; Tommy Olsson; Steven E Kahn
Ethnic differences in serum lipoproteins and their determinants in South African women.
Metabolism: clinical and experimental 2010;59(9):1341-50.
2010: Kaspar Berneis; Manfredi Rizzo; Heiner K Berthold; Giatgen A Spinas; Wilhelm Krone; Ioanna Gouni-Berthold
Ezetimibe alone or in combination with simvastatin increases small dense low-density lipoproteins in healthy men: a randomized trial.
European heart journal 2010;31(13):1633-9.
2010: Kaspar Berneis; Manfredi Rizzo; J Evans; Giovam Battista Rini; Giatgen A Spinas; J H Goedecke
Interleukin-18 levels are associated with low-density lipoproteins size.
European journal of clinical investigation 2010;40(1):54-5.
2009: Manfredi Rizzo; Giatgen A Spinas; Mustafa Cesur; Zeynep Ozbalkan; Giovam Battista Rini; Kaspar Berneis
Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis.
Atherosclerosis 2009;207(2):502-6.
2009: Manfredi Rizzo; Ali A Rizvi; Giatgen A Spinas; Giovam Battista Rini; Kaspar Berneis
Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP-4-inhibitors.
Expert opinion on investigational drugs 2009;18(10):1495-503.
2009: Manfredi Rizzo; Kaspar Berneis; Martin Hersberger; Ilenia Pepe; Gaetana Di Fede; Giovam Battista Rini; Giatgen A Spinas; Enrico Carmina
Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype.
Human reproduction (Oxford, England) 2009;24(9):2286-92.
2009: Ruzena Tkacova; Manfredi Rizzo; Kaspar Berneis
Therapy with noninvasive ventilation in patients with obstructive sleep apnoea: effects on atherogenic lipoprotein phenotype.
Medical hypotheses 2009;73(3):441-4.
2009: Kaspar Berneis; Manfredi Rizzo; Giatgen A Spinas; Gabriele Di Lorenzo; Gaetana Di Fede; Ilenia Pepe; Vincenzo Pernice; Giovam Battista Rini
The predictive role of atherogenic dyslipidemia in subjects with non-coronary atherosclerosis.
Clinica chimica acta; international journal of clinical chemistry 2009;406(1-2):36-40.
2009: Manfredi Rizzo; Giovam Battista Rini; Giatgen A Spinas; Kaspar Berneis
The effects of ezetimibe on LDL-cholesterol: quantitative or qualitative changes?
Atherosclerosis 2009;204(2):330-3.
2009: Manfredi Rizzo; Vincenzo Pernice; Arian Frasheri; Gabriele Di Lorenzo; Giovam Battista Rini; Giatgen A Spinas; Kaspar Berneis
Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome.
Clinical endocrinology 2009;70(6):870-5.
2009: Manfredi Rizzo; Pierre-Alex Krayenbühl; Vincenzo Pernice; Arian Frasheri; Giovam Battista Rini; Kaspar Berneis
LDL size and subclasses in patients with abdominal aortic aneurysm.
International journal of cardiology 2009;134(3):406-8.
2009: Manfredi Rizzo; Jelena Kotur-Stevuljevic; Kaspar Berneis; Giatgen Spinas; Giovam Battista Rini; Zorana Jelic-Ivanovic; Vesna Spasojevic-Kalimanovska; Jelena Vekic
Atherogenic dyslipidemia and oxidative stress: a new look.
Translational research : the journal of laboratory and clinical medicine 2009;153(5):217-23.
2009: Manfredi Rizzo; Kaspar Berneis; Giatgen Spinas; Giovam Battista Rini; Enrico Carmina
Long-term consequences of polycystic ovary syndrome on cardiovascular risk.
Fertility and sterility 2009;91(4 Suppl):1563-7.
2009: Manfredi Rizzo; Kaspar Berneis; Giatgen A Spinas; Giovam Battista Rini; N K Kapur
Quantitative and qualitative effects of rosuvastatin on LDL-cholesterol: what is the clinical significance?
International journal of clinical practice 2009;63(3):478-85.
2009: Manfredi Rizzo; Ali A Rizvi; Giovam Battista Rini; Kaspar Berneis
The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance?
Acta diabetologica 2009;46(1):1-11.
2009: Manfredi Rizzo; Kaspar Berneis; Aleksandra Zeljkovic; Jelena Vekic
Should we routinely measure low-density and high-density lipoprotein subclasses?
Clinical laboratory 2009;55(11-12):421-9.
2009: Kaspar Berneis; M Rizzo; Martin Hersberger; G B Rini; G Di Fede; I Pepe; Giatgen A Spinas; Enrico Carmina
Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome.
International journal of clinical practice 2009;63(1):56-62.
2008: M Rizzo; Kaspar Berneis; A E Altinova; F B Toruner; M Akturk; G Ayvaz; G B Rini; Giatgen A Spinas; M Arslan
Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes.
Diabetic medicine : a journal of the British Diabetic Association 2008;25(12):1406-11.
2008: Manfredi Rizzo; Kaspar Berneis
Recent insights on dark chocolate consumption and cardiovascular risk.
Southern medical journal 2008;101(12):1194.
2008: Manfredi Rizzo; Emanuel R Christ; Giovam Battista Rini; Giatgen A Spinas; Kaspar Berneis
The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance?
Expert opinion on pharmacotherapy 2008;9(13):2295-303.
2008: Manfredi Rizzo; Roman Trepp; Kaspar Berneis; Emanuel R Christ
Post-prandial alterations in LDL size and subclasses in patients with growth hormone deficiency.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2008;18(3):264-6.
2008: Barbara Elke; L Käser; Kaspar Berneis; Giatgen Spinas; Edouard Battegay
[Diabetes mellitus--diagnosis and blood glucose control].
Praxis 2008;97(10):529-37; quiz 538-9.
2008: Pierre A Krayenbuehl; Peter Wiesli; Christoph Schmid; Roger Lehmann; Giatgen A Spinas; Kaspar Berneis
Insulin sensitivity in type 2 diabetes is closely associated with LDL particle size.
Swiss medical weekly 2008;138(19-20):275-80.
2008: Manfredi Rizzo; Vincenzo Pernice; Arian Frasheri; Kaspar Berneis
Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease.
Atherosclerosis 2008;197(1):237-41.
2008: Kaspar Berneis; Manfredi Rizzo; Christoph Stettler; Bernard Chappuis; Monica Braun; Peter Diem; Emanuel R Christ
Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial low-density lipoprotein size and subclasses in patients with Type 2 diabetes.
Expert opinion on pharmacotherapy 2008;9(3):343-9.
2008: Manfredi Rizzo; Kaspar Berneis; Enrico Carmina; Giovam Battista Rini
How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome?
American journal of obstetrics and gynecology 2008;198(1):28.e1-5.
2007: M Rizzo; Kaspar Berneis
Who needs to care about small, dense low-density lipoproteins?
International journal of clinical practice 2007;61(11):1949-56.
2007: Isabelle Aeberli; Michael B Zimmermann; Luciano Molinari; Roger Lehmann; Dagmar l'Allemand; Giatgen A Spinas; Kaspar Berneis
Fructose intake is a predictor of LDL particle size in overweight schoolchildren.
The American journal of clinical nutrition 2007;86(4):1174-8.
2007: Gabor Szinnai; Nils G. Morgenthaler; Kaspar Berneis; Joachim Struck; Beat Müller; Ulrich Keller; Mirjam Christ-Crain
Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects.
The Journal of clinical endocrinology and metabolism 2007;92(10):3973-8.
2007: Manfredi Rizzo; Kaspar Berneis
Update on the role of the atherogenic lipoprotein phenotype in cardiovascular prevention.
Future cardiology 2007;3(5):553-8.
2007: M Rizzo; Giovam Battista Rini; Kaspar Berneis
The clinical relevance of LDL size and subclasses modulation in patients with type-2 diabetes.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2007;115(8):477-82.
2007: S Lüthold; Kaspar Berneis; Pierre Bady; Beat Müller
Effects of infectious disease on plasma lipids and their diagnostic significance in critical illness.
European journal of clinical investigation 2007;37(7):573-9.
2007: Manfredi Rizzo; Kaspar Berneis
An update on the role of the quality of LDL in cardiovascular risk: the contribution of the universities of Palermo and Zurich.
Recent patents on cardiovascular drug discovery 2007;2(2):85-8.
2007: Manfredi Rizzo; Giovam Battista Rini; Kaspar Berneis
Effects of statins, fibrates, rosuvastatin, and ezetimibe beyond cholesterol: the modulation of LDL size and subclasses in high-risk patients.
Advances in therapy 2007;24(3):575-82.
2007: Manfredi Rizzo; Kaspar Berneis
The clinical significance of the size of low-density-lipoproteins and the modulation of subclasses by fibrates.
Current medical research and opinion 2007;23(5):1103-11.
2007: Manfredi Rizzo; Roman Trepp; Kaspar Berneis; Emanuel R Christ
Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy.
European journal of endocrinology / European Federation of Endocrine Societies 2007;156(3):361-7.
2007: Manfredi Rizzo; Kaspar Berneis
Small, dense low-density-lipoproteins and the metabolic syndrome.
Diabetes/metabolism research and reviews 2007;23(1):14-20.
2007: Kaspar Berneis; Manfredi Rizzo; Veronica Lazzarini; Veronica Lazzaroni; Franca Fruzzetti; Enrico Carmina
Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome.
The Journal of clinical endocrinology and metabolism 2007;92(1):186-9.
2006: Manfredi Rizzo; Kaspar Berneis
The clinical relevance of low-density-lipoproteins size modulation by statins.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2006;20(3):205-17.
2006: Manfredi Rizzo; Kaspar Berneis; Egle Corrado; Salvatore Novo
The significance of low-density-lipoproteins size in vascular diseases.
International angiology : a journal of the International Union of Angiology 2006;25(1):4-9.
2006: Manfredi Rizzo; Kaspar Berneis
Low-density lipoprotein size and cardiovascular prevention.
European journal of internal medicine 2006;17(2):77-80.
2006: Manfredi Rizzo; Kaspar Berneis
Should we measure routinely the LDL peak particle size?
International journal of cardiology 2006;107(2):166-70.
2006: Manfredi Rizzo; Kaspar Berneis
Low-density lipoprotein size and cardiovascular risk assessment.
QJM : monthly journal of the Association of Physicians 2006;99(1):1-14.
2005: Manfredi Rizzo; Pasquale Mansueto; Daniela Cabibi; Elisabetta Barresi; Kaspar Berneis; Mario Affronti; Gabriele Di Lorenzo; Sergio Vigneri; Giovam Battista Rini
A case of bowel schistosomiasis not adhering to endoscopic findings.
World journal of gastroenterology : WJG 2005;11(44):7044-7.
2005: H Robert Superko; Kaspar Berneis; Paul T Williams; Manfredi Rizzo; Peter D Wood
Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A.
The American journal of cardiology 2005;96(9):1266-72.
2005: Kaspar Berneis; Christina Jeanneret; Jürgen Muser; Barbara Felix; André R Miserez
Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
Metabolism: clinical and experimental 2005;54(2):227-34.
2005: Manfredi Rizzo; Kaspar Berneis
Lipid triad or atherogenic lipoprotein phenotype: a role in cardiovascular prevention?
Journal of atherosclerosis and thrombosis 2005;12(5):237-9.
2004: Kaspar Berneis; David M Shames; Patricia J Blanche; Michael La Belle; Manfredi Rizzo; Ronald M Krauss
Plasma clearance of human low-density lipoprotein in human apolipoprotein B transgenic mice is related to particle diameter.
Metabolism: clinical and experimental 2004;53(4):483-7.
2004: Manfredi Rizzo; John M Taylor; Carlo M Barbagallo; Kaspar Berneis; Patricia J Blanche; Ronald M Krauss
Effects on lipoprotein subclasses of combined expression of human hepatic lipase and human apoB in transgenic rabbits.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(1):141-6.
2003: Ulrich Keller; Gabor Szinnai; Stefan Bilz; Kaspar Berneis
Effects of changes in hydration on protein, glucose and lipid metabolism in man: impact on health.
European journal of clinical nutrition 2003;57 Suppl 2():S69-74.
2003: Kaspar Berneis; Carlos Buitrago-Téllez; Beat Müller; Ulrich Keller; Dimitrios A Tsakiris
Antiphospholipid syndrome and endocrine damage: why bilateral adrenal thrombosis?
European journal of haematology 2003;71(4):299-302.
2002: Kaspar Berneis; Jean-Jacques Staub; A Gessler; Christian Meier; J Girard; Beat Müller
Combined stimulation of adrenocorticotropin and compound-S by single dose metyrapone test as an outpatient procedure to assess hypothalamic-pituitary-adrenal function.
The Journal of clinical endocrinology and metabolism 2002;87(12):5470-5.
2002: Kaspar Berneis; Ronald M Krauss
Metabolic origins and clinical significance of LDL heterogeneity.
Journal of lipid research 2002;43(9):1363-79.
2002: Kaspar Berneis; Michael La Belle; Patricia J Blanche; Ronald M Krauss
Analysis and quantitation of biotinylated apoB-containing lipoproteins with streptavidin-Cy3.
Journal of lipid research 2002;43(7):1155-9.
2000: Kaspar Berneis; Manuel Battegay; S Bassetti; Reto Nüesch; A Leisibach; Stefan Bilz; Ulrich Keller
Nutritional supplements combined with dietary counselling diminish whole body protein catabolism in HIV-infected patients.
European journal of clinical investigation 2000;30(1):87-94.
1999: Kaspar Berneis; J Iseli-Schaub; E Garbani; R Meier; D Kiss
Effects of intradialytic parenteral nutrition in chronic haemodialysis patients with malnutrition: a pilot study.
Wiener klinische Wochenschrift 1999;111(21):876-81.
1999: Kaspar Berneis; M Oehri; Marius Kraenzlin; U Keller
Effects of IGF-I combined with GH on glucocorticoid-induced changes of bone and connective tissue turnover in man.
The Journal of endocrinology 1999;162(2):259-64.
1999: Kaspar Berneis; R Ninnis; D Häussinger; Ulrich Keller
Effects of hyper- and hypoosmolality on whole body protein and glucose kinetics in humans.
The American journal of physiology 1999;276(1 Pt 1):E188-95.
1997: Kaspar Berneis; R Ninnis; J Girard; B M Frey; Ulrich Keller
Effects of insulin-like growth factor I combined with growth hormone on glucocorticoid-induced whole-body protein catabolism in man.
The Journal of clinical endocrinology and metabolism 1997;82(8):2528-34.
1997: Kaspar Berneis; R Ninnis; Ulrich Keller
Ethanol exerts acute protein-sparing effects during postabsorptive but not during anabolic conditions in man.
Metabolism: clinical and experimental 1997;46(7):750-5.
1996: Kaspar Berneis; S Vosmeer; Ulrich Keller
Effects of glucocorticoids and of growth hormone on serum leptin concentrations in man.
European journal of endocrinology / European Federation of Endocrine Societies 1996;135(6):663-5.